Molekulargenetische Diagnostik
Praxis Dr. Mato Nagel

MSH2-Gen

Das MSH2-Gen wurde bei hereditärem nichtpolypösem Coloncarcinom mutiert gefunden.

Diagnostik:

Clinic Untersuchungsmethoden Multiplex ligationsabhängige Amplifikation
Bearbeitungszeit 25
Probentyp genomic DNA
Clinic Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25
Probentyp genomic DNA

Krankheiten:

Referenzen:

1.

Wang Y et al. (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.

[^]
2.

Vilkki S et al. (2001) Extensive somatic microsatellite mutations in normal human tissue.

[^]
3.

Ellison AR et al. (2001) Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae.

[^]
4.

Mangold E et al. (2004) A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome.

[^]
5.

Alazzouzi H et al. (2005) Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis.

[^]
6.

Quehenberger F et al. (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment.

[^]
7.

Pagenstecher C et al. (2006) Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.

[^]
8.

Kurzawski G et al. (2006) Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study).

[^]
9.

Barnetson RA et al. (2006) Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.

[^]
10.

Tournier I et al. (2008) A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects.

[^]
11.

Maliaka YK et al. (1996) CpG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations.

[^]
12.

Genuardi M et al. (1998) Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility.

[^]
13.

Ricciardone MD et al. (1999) Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1.

[^]
14.

Wang Q et al. (1999) Neurofibromatosis and early onset of cancers in hMLH1-deficient children.

[^]
15.

Froggatt NJ et al. (1999) A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.

[^]
16.

Gradia S et al. (1999) hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA.

[^]
17.

Ni TT et al. (1999) MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae.

[^]
18.

Yuan ZQ et al. (1999) A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening.

[^]
19.

Yan H et al. (2000) Conversion of diploidy to haploidy.

[^]
20.

Desai DC et al. (2000) Recurrent germline mutation in MSH2 arises frequently de novo.

[^]
21.

Lamers MH et al. (2000) The crystal structure of DNA mismatch repair protein MutS binding to a G x T mismatch.

[^]
22.

Whiteside D et al. (2002) A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple café-au-lait spots.

[^]
23.

Wang Y et al. (2002) A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1.

[^]
24.

Wagner A et al. (2002) A 10-Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred.

[^]
25.

Brown KD et al. (2003) The mismatch repair system is required for S-phase checkpoint activation.

[^]
26.

Foulkes WD et al. (2002) The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.

[^]
27.

Bougeard G et al. (2003) Early onset brain tumor and lymphoma in MSH2-deficient children.

[^]
28.

Wheeler VC et al. (2003) Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum.

[^]
29.

Wagner A et al. (2003) Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.

[^]
30.

Pyatt RE et al. (2003) Identification of a deletion in the mismatch repair gene, MSH2, using mouse-human cell hybrids monosomal for chromosome 2.

[^]
31.

Jin YH et al. (2003) Cadmium is a mutagen that acts by inhibiting mismatch repair.

[^]
32.

McMurray CT et al. (2003) Cancer, cadmium and genome integrity.

[^]
33.

Lynch HT et al. (2004) A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States.

[^]
34.

Barana D et al. (2004) Spectrum of genetic alterations in Muir-Torre syndrome is the same as in HNPCC.

[^]
35.

Chan TL et al. (2004) MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population.

[^]
36.

Duval A et al. (2004) The mutator pathway is a feature of immunodeficiency-related lymphomas.

[^]
37.

Kovtun IV et al. (2004) Somatic deletion events occur during early embryonic development and modify the extent of CAG expansion in subsequent generations.

[^]
38.

Wada-Hiraike O et al. (2005) The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor alpha.

[^]
39.

van der Klift H et al. (2005) Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).

[^]
40.

Sun S et al. (2005) The HNPCC associated MSH2*1906G-->C founder mutation probably originated between 1440 CE and 1715 CE in the Ashkenazi Jewish population.

[^]
41.

Chan TL et al. (2006) Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer.

[^]
42.

Stella A et al. (2007) Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.

[^]
43.

Kets CM et al. (2009) Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A>G of MSH2.

[^]
44.

Lishanski A et al. (1994) Mutation detection by mismatch binding protein, MutS, in amplified DNA: application to the cystic fibrosis gene.

[^]
45.

Reitmair AH et al. (1995) MSH2 deficient mice are viable and susceptible to lymphoid tumours.

[^]
46.

de Wind N et al. (1995) Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.

[^]
47.

Kolodner RD et al. (1994) Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations.

[^]
48.

Wijnen J et al. (1995) Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis.

[^]
49.

Mary JL et al. (1994) Mutational analysis of the hMSH2 gene reveals a three base pair deletion in a family predisposed to colorectal cancer development.

[^]
50.

Orth K et al. (1994) Genetic instability in human ovarian cancer cell lines.

[^]
51.

Fishel R et al. (1994) Binding of mismatched microsatellite DNA sequences by the human MSH2 protein.

[^]
52.

Liu B et al. (1994) hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds.

[^]
53.

Aquilina G et al. (1994) A mismatch recognition defect in colon carcinoma confers DNA microsatellite instability and a mutator phenotype.

[^]
54.

Umar A et al. (1994) Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability.

[^]
55.

Fishel R et al. (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

[^]
56.

Leach FS et al. (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

[^]
57.

Jeon HM et al. (1996) Mutation of the hMSH2 gene in two families with hereditary nonpolyposis colorectal cancer.

[^]
58.

Lowsky R et al. (1997) Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL).

[^]
59.

Pearson CE et al. (1997) Human MSH2 binds to trinucleotide repeat DNA structures associated with neurodegenerative diseases.

[^]
60.

Esche C et al. (1997) Muir-Torre syndrome: clinical features and molecular genetic analysis.

[^]
61.

Gradia S et al. (1997) The human mismatch recognition complex hMSH2-hMSH6 functions as a novel molecular switch.

[^]
62.

DeWeese TL et al. (1998) Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation.

[^]

 

 
Ihre Nachricht: